Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Compugen Ltd (NASDAQ:CGEN)

3.10
Delayed Data
As of 10:56am ET
 -0.15 / -4.62%
Today’s Change
2.25
Today|||52-Week Range
5.40
+24.00%
Year-to-Date
No recent news for Compugen Ltd.

Today’s Trading

Previous close3.25
Today’s open3.40
Day’s range3.06 - 3.40
Volume120,397
Average volume (3 months)164,870
Market cap$166.2M
Data as of 10:56am ET, 01/19/2018

Growth & Valuation

Earnings growth (last year)-55.00%
Earnings growth (this year)-19.35%
Earnings growth (next 5 years)--
Revenue growth (last year)-92.33%
P/E ratioNM
Price/Sales364.28
Price/Book2.62

Competitors

 Today’s
change
Today’s
% change
VBIVVBI Vaccines Inc+0.06+1.45%
VBLTVascular Biogenics L...+0.10+1.32%
FATEFate Therapeutics In...-0.02-0.28%
GNCAGenocea Biosciences ...+0.03+3.19%
Data as of 11:13am ET, 01/19/2018

Financials

Next reporting dateFebruary 13, 2018
EPS forecast (this quarter)-$0.20
Annual revenue (last year)$712.0K
Annual profit (last year)-$31.5M
Net profit margin-4,425.00%

Profile

Sector
Health Technology
Industry
Biotechnology
President &
Chief Executive Officer
Anat Cohen-Dayag
Chief Operating &
Financial Officer
Ari Krashin
Corporate headquarters
Holon, Tel Aviv

Forecasts